Cargando…
BICD1 expression, as a potential biomarker for prognosis and predicting response to therapy in patients with glioblastomas
There is variation in the survival and therapeutic outcome of patients with glioblastomas (GBMs). Therapy resistance is an important challenge in the treatment of GBM patients. The aim of this study was to identify Temozolomide (TMZ) related genes and confirm their clinical relevance. The TMZ-relate...
Autores principales: | Huang, Shang-Pen, Chang, Yu-Chan, Low, Qie Hua, Wu, Alexander T.H., Chen, Chi-Long, Lin, Yuan-Feng, Hsiao, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768362/ https://www.ncbi.nlm.nih.gov/pubmed/29371945 http://dx.doi.org/10.18632/oncotarget.22667 |
Ejemplares similares
-
BICD Cargo Adaptor 1 (BICD1) Downregulation Correlates with a Decreased Level of PD-L1 and Predicts a Favorable Prognosis in Patients with IDH1-Mutant Lower-Grade Gliomas
por: Huang, Shang-Pen, et al.
Publicado: (2021) -
Enrichment of Aldolase C Correlates with Low Non-Mutated IDH1 Expression and Predicts a Favorable Prognosis in Glioblastomas
por: Chang, Yu-Chan, et al.
Publicado: (2019) -
Coil-to-α-helix transition at the Nup358-BicD2 interface activates BicD2 for dynein recruitment
por: Gibson, James M, et al.
Publicado: (2022) -
Elevated BICD2 DNA methylation in blood of major depressive disorder patients and reduction of depressive-like behaviors in hippocampal Bicd2-knockdown mice
por: Xiu, Jianbo, et al.
Publicado: (2022) -
Identification of core genes as potential biomarkers for predicting progression and prognosis in glioblastoma
por: Zeng, Jianping, et al.
Publicado: (2022)